| Nina Davis, NP | |
|
1247 E Mockingbird Ln, Sandy, UT 84094-3118 | |
| (419) 366-8406 | |
| Not Available |
| Full Name | Nina Davis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1247 E Mockingbird Ln, Sandy, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265090922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 816789 (Nevada) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 10560013-1302 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lds Hospital | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
A new study published in the current issue of Psychotherapy and Psychosomatics indicates the long-term positive effects of cognitive-behavioral therapy for trauma in children and adolescents.
PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.
Blood stem cells have the potential to turn into any type of blood cell, whether it be the oxygen-carrying red blood cells, or the many types of white blood cells of the immune system that help fight infection.
› Verified 3 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
A new study published in the current issue of Psychotherapy and Psychosomatics indicates the long-term positive effects of cognitive-behavioral therapy for trauma in children and adolescents.
PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.
Blood stem cells have the potential to turn into any type of blood cell, whether it be the oxygen-carrying red blood cells, or the many types of white blood cells of the immune system that help fight infection.
› Verified 3 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
A new study published in the current issue of Psychotherapy and Psychosomatics indicates the long-term positive effects of cognitive-behavioral therapy for trauma in children and adolescents.
PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.
Blood stem cells have the potential to turn into any type of blood cell, whether it be the oxygen-carrying red blood cells, or the many types of white blood cells of the immune system that help fight infection.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nina Davis, NP 1247 E Mockingbird Ln, Sandy, UT 84094-3118 Ph: () - | Nina Davis, NP 1247 E Mockingbird Ln, Sandy, UT 84094-3118 Ph: (419) 366-8406 |
News Archive
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
A new study published in the current issue of Psychotherapy and Psychosomatics indicates the long-term positive effects of cognitive-behavioral therapy for trauma in children and adolescents.
PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.
Blood stem cells have the potential to turn into any type of blood cell, whether it be the oxygen-carrying red blood cells, or the many types of white blood cells of the immune system that help fight infection.
› Verified 3 days ago
Loandra Berg, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9450 S 1300 E, Ste 110, Sandy, UT 84094 Phone: 801-501-6100 | |
Angela Marie Miller, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11562 S Hickory Valley Dr, Sandy, UT 84092 Phone: 435-901-1995 | |
Theresa Brooke Sligting, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3080 E Granite Slope Ln, Sandy, UT 84092 Phone: 801-699-6526 | |
Deana Marie Busch, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8899 S 700 E Ste 250, Sandy, UT 84070 Phone: 801-999-8252 | |
Benjamin Zachariah Rollins, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 476 E Mingo Park Dr, Sandy, UT 84070 Phone: 801-554-4784 | |
Mr. Eugene Ray Snyder, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-662-4275 | |
Jennifer Lyn Aragon, A.P.R.N. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9980 S 300 W Ste 200, Sandy, UT 84070 Phone: 385-495-4151 Fax: 844-596-0409 |